GuidanceMHRA
Importing investigational medicinal products into Great Britain from approved countries
Outlining the principles for the management and oversight of the import of investigational medicinal products (IMPs) to Great Britain from listed countries.
First published: Dec 31, 2020Last updated: Feb 12, 2025Changes: 4
Latest change: Updated guidance document updated to take account of the EU implementation of the Clinical Trials Regulation No 536/2014 related to EU QP certification.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.